Chronic myelogenous leukemia primary prevention

Jump to: navigation, search

Chronic myelogenous leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic myelogenous leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic myelogenous leukemia primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic myelogenous leukemia primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic myelogenous leukemia primary prevention

CDC on Chronic myelogenous leukemia primary prevention

Chronic myelogenous leukemia primary prevention in the news

Blogs on Chronic myelogenous leukemia primary prevention

Directions to Hospitals Treating Chronic myelogenous leukemia

Risk calculators and risk factors for Chronic myelogenous leukemia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] Mohamad Alkateb, MBBCh [3] Sima NoorAli, M.D.

Overview

Since chronic myeloid leukemia is associate with genetic mutation so there are no primary preventive measures available for chronic myelogenous leukemia. However, prevention of radiation exposure can be associated with lesser events of transformation of chronic phase to accelerated phase.

Primary prevention

  • Prevention of radiation exposure is associated with decreased risk of transformation of chronic phase to accelerated phase.[1][2]

References

  1. American Cancer Society 2015.http://www.cancer.org/cancer/leukemia-chronicmyeloidcml/detailedguide/leukemia-chronic-myeloid-myelogenous-prevention
  2. Corso A, Lazzarino M, Morra E, Merante S, Astori C, Bernasconi P, Boni M, Bernasconi C (February 1995). "Chronic myelogenous leukemia and exposure to ionizing radiation--a retrospective study of 443 patients". Ann. Hematol. 70 (2): 79–82. PMID 7880928.

Linked-in.jpg